Conmed Corp (CNMD) Reports In-Line Q2 EPS; Guides Q3
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $35.95 +4.02%
Revenue Growth %: -0.5%
Financial Fact:
Net Income Diluted: 0.26
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: -0.5%
Financial Fact:
Net Income Diluted: 0.26
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Conmed Corp (NASDAQ: CNMD) reported Q2 EPS of $0.35, in-line with the analyst estimate of $0.35. Revenue for the quarter came in at $183.2 million versus the consensus estimate of $185.81 million.
Conmed Corp sees Q3 2011 EPS of $0.29-$0.33, versus the consensus of $0.33. Sees revs down slightly sequentially.
Conmed Corp sees Q3 2011 EPS of $0.29-$0.33, versus the consensus of $0.33. Sees revs down slightly sequentially.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
- BlackBerry surges on earnings beat and strong cash flow
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
